chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Customer rec'd first dose of COVID-19 vaccine approximately 18:07 and transferred to post vaccine observation. At 18:20 customer reports feeling nauseated with rapid onset occipital headache radiating into eyes at 7/10. She reports feeling "sweaty" and is flushed in appearance. Customer moved to ante room, closer to emergency supplies. Customer denies feeling SOB, difficulty breathing or tongue/throat swelling. O2 sat monitor not reading to due nail polish. BP 160/105, HR 88 (RRR) R 20 (unlabored). Lungs CTA. History of hypertension when pregnant but does not take medications at this time. History of kidney stones and "stuff." Customer accepts BENADRYL 50mg PO at 18:28. Customer monitored at site. Customer downplays symptoms and is a difficult historian. Does not wish to lay down. States "I'll be fine" and wishes to drive home to lay down. Customer given snack and water. Reports ongoing nausea with blurry eyes. Continues to rub her neck and shrug her shoulders up and appears quite uncomfortable. She reports history of significant nausea post flu shot which resolved within a couple of hours. Denies history of migraines. Denies known allergies and has never been given epinephrine. She denies taking any medications prior to receiving this vaccine. Reports heaviness in eyes and photophobia. TYLENOL 1000mg PO given at 19:00. Customer again begins flushing, feeling nauseated and diaphoretic. Admits to her symptoms worsening. She reports feeling like she wants to pass out and throw up. Continues to deny respiratory symptoms. BP 135/78, HR 86, RR 18. Denies decrease in headache "feels like I can't even hold my head up. It hurts so bad." She becomes tearful and is agreeable to transfer to ED for further work up and evaluation. Customer gives verbal consent to share medical information with mother, who is given ED phone number for follow up. Customer escorted via wheelchair by RN staff member. Handoff report given to, ED physician. Customer is aware that this information will be shared with her PCP Team for follow up. Recommend consult prior to next vaccine appointment to discuss post vaccine course and discuss risks/benefits and/or pre-treatments prior to next vaccine.
Blood Pressure elevated to 190/110 almost 2 hours after receiving the vaccine; Hives which are healing but still present today and shortness of breath which continues and extreme fatigue.
Tinnitus in both ears Nearly Constant dizziness Hearing loss in left ear Tingling pins and needles in arms, hands, feet, and legs Tight and numb forehead  Numbness in top gums Frequent headaches  Nauseous when dizzy Sore Throat
Patient only received half of the dose after the second attempt due to resistance.  Faulty syringe is suspected.  Patient felt some lightheadedness during the attempts but it resolved soon after.  After consulting with Moderna, staff administered a second dose on the opposite arm with no issues.
Severe itchy throat,constant nose irritation & sneezing,severe eye itchiness with redness of the eye & pupil dilated,fatigue,jaw pain.
pt recvd vax in 1990 & devel fat necrosis @ inject site; No further details were provided;
Chills, I felt quite cold, put on multiple layers, turned house heat up, went to bed, covered again in multiple layers and felt like I was freezing
THERE WAS NO ADVERSE EVENT, PATIENT GIVEN MONO INSTEAD OF BIVALENT
This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in the right arm on 14May2021 at 13:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic lymphocytic leukemia (CLL). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 20May2021, the patient experienced neutrophilic dermatoses on crotch, legs and feet. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in Aug2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was negative. The clinical outcome of the event neutrophilic dermatoses on crotch, legs and feet was resolved with sequelae on an unknown date in 2021. The patient also received the second dose of BNT162b2 (COMIRNATY; Lot Number: EW0179) via an unspecified route of administration in the left arm on 04Jun2021 at 13:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation.No follow-up attempts are possible. No further information is expected.
pt devel hives approx 4hr p/vax which occurred intermittently through that noc & next day;took DPH & had no further hives;also had sore throat & was achy for 2 days;
Information has been received from a medical assistant referring to an unknown number of unspecified patients of unknown age and gender. Information regarding pertinent medication, drug reactions/allergies and concomitant medication were not reported. On unknown dates starting on or after 21-JUL-2016, the patients were administered improperly stored doses of VARIVAX lot # L039092 with expiration date 06-OCT-2017 (dose and route were not reported). The temperature excursion was 10.89 Fahrenheit and time frame was 12 hours. There was no previous temperature excursion. No adverse effect was reported. Additional information has been requested.
My daughter developed a rash that has persisted for over 3 weeks now. She was originally misdiagnosed as having poison ivy and was given 2 steroid shots. That helped for a few days. She then saw the regular Dr who said it was a virus and was given 5 days f oral steroids.  The rash has persisted coming and going regularly in different locations all over the body. My daughter has also been much more tired than normal.  The regular Dr has referred her to dermatology but she can?t get in to be seen for several weeks.
Information has been received from a physician concerning a 13 month old male, weight 23lb, who on 31-MAR-2008 at 10:45 was vaccinated with the first dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) in the left thigh (lot#:657780/0617U). On 20-APR-2008, the patient developed chickenpox. On
did not sleep for 4 nights; This case was reported by a nurse via call center representative and described the occurrence of sleep loss in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included autoimmune thyroiditis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced sleep loss. On an unknown date, the outcome of the sleep loss was unknown.   It was unknown if the reporter considered the sleep loss to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient was a nurse. The patient given an unspecified dose number of Shingrix and did not sleep for 4 nights. No other events were reported. It was reported that very uncooperative reporter and patient would not participate in a safety report or provide any demographics. The reporter did not consent to follow up.
bumps spread from her right breast to her right armpit; Rash; Chills; This case was reported by a consumer via call center representative and described the occurrence of rash in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, 48 hrs after receiving Shingrix, the patient experienced rash, chills and local swelling. On an unknown date, the outcome of the rash and chills were recovered/resolved and the outcome of the local swelling was unknown.   It was unknown if the reporter considered the rash, chills and local swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient reported that after receiving the second Shingrix vaccine approximately two years ago in right arm. The patient had Chills on the day after receiving the vaccination. The chills had resolved by the next day. The patient noticed a rash or bumps on her breast approximately forty eight hours after the vaccination. The bumps spread from her right breast to her right armpit. The Rash lasted approximately ten days. The Rash reappeared approximately four days later and lasted five days. The third time the rash appeared, it lasted approximately three days.  The patient  had the rash three separate times exactly fourteen days apart. Each episode was less severe than the previous one. The patient consented to follow up.
incorrect product storage; This spontaneous report was received from a nurse and refers to a patient of unknown age.  The patient's concurrent conditions, medical history, concomitant therapies were not provided.  On an unknown date, the patient was vaccinated with 0.5 ml hepatitis A vaccine, inactivated(VAQTA)( lot # T031202 with expiration date: 14-JUN-2022)for prophylaxis. The vaccine was administered after temperature excursion (14.1 Celsius degrees in a timeframe of 14 hours). There was no previous temperature excursions (product storage error).
MENSTRUAL CYCLE HAS ALWAYS BEEN NORMAL AND ON TIME. NEVER ANY ISSUES UNTIL NOW. TWO CYCLES (PERIODS) IN AUGUST 2021 AND THEN NOTHING AT ALL FOR THE MONTH OF SEPTEMBER 2021. FOR 4 WEEKS PLUS EXPERIENCED HORRIBLE PMS SYMPTOMS WITH NO MENSTRATION. CYCLE THAT CAME MID OCTOBER WAS COMPLETELY ABNORMAL, HEAVY, AND PAINFUL. CONTINUOUS & CHONIC FATIGUE SINCE!!!!!!!!!
pain in her fingers wrist and hand along with swelling; pain in her fingers wrist and hand along with swelling; Initial information was received on 17-Nov-2020 regarding an unsolicited valid non-serious case from a pharmacist.  This case involves a 79-year-old female patient who experienced pain in her fingers wrist and hand along with swelling (pain in extremity and (peripheral swelling), while she received INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On 03-Oct-2020, the patient received a dose of 0.7 ml suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ479AA, 30-Jun-2021) via intramuscular route at an unknown administration site for prophylactic vaccination.  On 10-Oct-2020, the patient developed a non-serious pain in her fingers wrist and hand along with swelling (pain in extremity and (peripheral swelling) 7 days following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the events.
arm starting hurting; This is a spontaneous report from a contactable consumer or other non hcp. A 72-years-old female patient received BNT162B2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm on Jan2021 (Batch/Lot number was not reported) as single dose, dose 2 via an unspecified route of administration, administered in Arm on 23Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced arm starting hurting (pain in extremity), on an unknown date in Apr2021. The patient asked how many people had to report and got response as Stated there have been reports of muscle pain, but it does not specific how long after there vaccination that they felt the pain. The outcome of the event was unknown.  No follow-up attempts are possible; Information related to batch/Lot number could not be requested.
On Tuesday 7-3-07 pt came in for a physical - I asked him an 3 different encounters if he wanted a tetanus. The first two times he said no - the 3rd time I informed him he was going to have blood works did he want the shot. He said "OK". I gave him the Tdap vaccine (I tell all pts who came in for a physical if it has been at least 5 yrs since the last tetanus then lets go ahead and update the shot. On Thursday 7-5-07 the pt came in and informed me that he had a reaction to the vaccine. He stated he had a high fever and flu-like symptoms and numbness in his fingers. When asked if he was still experiencing the symptoms he said that his arm was still hurting and he still had some numbness in his fingers. I then gave him the lot# and insert of the Tdap vaccine he was given.
itching (itch) (just started 3 or 4 days ago) on back of neck; welted up; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching (itch) (just started 3 or 4 days ago) on back of neck) and URTICARIA (welted up) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Surgery (Neck surgery).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching (itch) (just started 3 or 4 days ago) on back of neck) and URTICARIA (welted up). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (itching (itch) (just started 3 or 4 days ago) on back of neck) and URTICARIA (welted up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
The patient is a 15-year-old male with no past medical history who was in his normal state of health when he received a dose to the Pfizer COVID-19 vaccine on June 10th 2021. The day following vaccine he developed fevers and chills which she treated with Tylenol.  On the morning of June 12 he developed chest pain and nausea which progressively worsened throughout the day.  That day he presented to an outside hospital emergency department where he was found to have elevated troponin and EKG with ST segment elevation.  He was then transferred to the hospital pediatric ICU for further care.  On admission to the PICU treatment was started with IV Toradol.  Echocardiogram was performed and revealed mildly decreased left ventricular systolic function.  His peak troponin level was 27.43.  He remains hemodynamically stable and was transferred to the pediatric floor.  By 6/14/2021 his chest pain had resolved and he continued to improve with NSAID therapy alone.  His troponin down trended to 2.62 on day of discharge.  Repeat echo on day of discharge showed improving but still mildly diminished systolic function.  Repeat ECG at discharge showed persistent ST elevation. He was discharged with a prescription to continue ibuprofen 600 mg 3 times daily and follow-up with pediatric cardiology in 1 to 2 weeks.
Immediately following immunization patient felt "light headed and dizzy" for 2 hours.  At 4:30 PM she began vomiting every 10- 15 minutes and eventually developed "dry heaves".  Shortly after this she developed a headache.  At approximately 7:30 PM on 01/31/2008 she began having diarrhea and "felt really bad". During the night she began experiencing hallucinations.
Vaccine given on 9/21/09. Developed chills, N/V, blisters on lips 7 hours after injection. Episode lasted 6 hours. N/V resolved in 24. Blisters on lips lasted 2 weeks. No medical treatment sought.
1/25/2008 11am - Tdap administered L Deltoid IM.  1/25/2008 9pm - Pt reports onset of mild pain and swelling to L deltoid.   1/26/2008 2:30am - pt reports she was awakened with moderate pain, increased swelling, mild body aches - took Advil 800mg.  Continued Advil every 8 hours.  1/26/2008 9pm- Dull headache, mild arm pain on advil.  1/27/2008 1:30am - Pt reports she was awakened with flu-like symptoms (moderate headache, chills, body aches). Oral temp. 104 degrees.  1/27/2008 afternoon - left arm swelling began to decrease.  1/28/2008 10am - T97.1 (last antipyretic-Advil 1/27 9pm). L Deltoid with 1cm light yellow ecchymosis, no other discoloration. Tenderness and mild swelling 7.5cm diameter.  L upper arm circumference 35.5cm.  R (dominant) upper arm 34.5cm.
Starting on the day of the vaccine 2nd dose,  I had a fever that evening.  I had a lot of pain on my left arm and high heart rate. I took Tylenol for the symptoms.  I woke up the next morning and felt ok.   After 2 days, I noticed a red rash on my chest.  It was not itchy or painful.  I went to Urgent Care and the doctor recommended ice pack and the rash  went away.  After 10 days, I had diarrhea and nausea.  I went to Urgent Care again, I was given Zofran medication for nausea and they ran some tests which all came back normal.  The nausea and diarrhea went away after 2-3 days.  Currently, I still have a little bit of difficulty breathing and shortness of breath.
BLOOD CLOT; This spontaneous report received from a patient via social media  a patient of unspecified age, race, ethnicity and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was healthy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) 1 total dose was not reported, administered on MAY-2021 for prophylactic vaccination (dose series 1). The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  The patient reported "I got vaccine in May 2020. By mid June my toes started turning purple. It was discovered that I have a blood clot, I get to spend holiday having open heart bypass surgery. I used to be healthy." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clot was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211243049- COVID-19 VACCINE AD26.COV2.S- Blood clot. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
48 degrees after MMR and Varicella- developed 4 days of fever, 104 Tmax. 4 days after injection red rash on torso-self-resolved.
He felt weird; A lot of tachycardia with his heart 15 or 20 minutes; Fever; Headache; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 43-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration on 22Apr2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 first dose of (PFIZER-BIONTECH COVID-19 VACCINE) for covid-19 immunisation. Patient received the second dose of the vaccine yesterday. Patient having symptoms at this moment. A couple hours after the vaccine he felt weird and had a lot of tachycardia with his heart for 15 or 20 minutes on 22Apr2021. He rested and today he feels the same (still having tachycardia). He got a fever last night and a headache and the other symptoms that are normal on Apr2021. He asked if the tachycardia is normal and if he needs to see a specialist? The outcome of the event tachycardia was not recovered and unknown for another events.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous non-valid report was received from a consumer via social media and refers to a female patient of unknown age (the reporter stated that she knew personally someone's daughter). The patient's concurrent conditions and medical history were not reported. On an unknown date, the patient was vaccinated with an unspecified human papillomavirus vaccine (manufacturer unknown) (dose, route, frequency, lot number and expiration date were not reported) for prophylaxis. Information regarding concomitant medications was not reported. On an unknown date, after vaccination, the patient experienced "the worst pain in her life" and couldn't even walk for weeks, after receiving the unspecified human papillomavirus vaccine (manufacturer unknown). No product quality complaint (PQC) was involved. At the reporting time, the outcome of abasia and severe pain was not reported. The reporter considered the events to be related to the unspecified human papillomavirus vaccine (manufacturer unknown). Upon internal review, the event abasia was considered to be a medically significant event and also serious due to consequent disability. Additionally, the reporter stated that she knew about some "devastating effects" after receiving the unspecified human papillomavirus vaccine (manufacturer unknown) (Captured in MARRS #: 1701USA008604) This is one of two reports received from the same reporter. Additional information is not expected, because the reporter could not be contacted.; Sender's Comments:  US-009507513-1701USA008604:
started having dizzies spells when they move their head, like if they are reading and move head around, or when they laid down at night and head hit the pillow at night, their health otherwise is fine; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (started having dizzies spells when they move their head, like if they are reading and move head around, or when they laid down at night and head hit the pillow at night, their health otherwise is fine) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039F21A, 001B21A and 008B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (started having dizzies spells when they move their head, like if they are reading and move head around, or when they laid down at night and head hit the pillow at night, their health otherwise is fine). At the time of the report, DIZZINESS (started having dizzies spells when they move their head, like if they are reading and move head around, or when they laid down at night and head hit the pillow at night, their health otherwise is fine) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported.  No treatment medication details was reported.  It was reported that when they move their head, like if they are reading and move head around, or when they laid down at night and head hit the pillow at night, their health otherwise was fine   This case was linked to MOD-2021-400114 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jan-2022: Follow-up received on 24-Jan-2022 contains significant information: Causality updated from related to not related for all event.
My throat feels like its closing up, it doesn't feel very sore but my voice is very hoarse.